O. Baykan Et Al. , "The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms.," Clinical laboratory , vol.65, no.4, 2019
Baykan, O. Et Al. 2019. The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms.. Clinical laboratory , vol.65, no.4 .
Baykan, O., Akgul, M., Uren, N., Yaman, A., Tinay, I., Ergul, E., ... Sazci, A.(2019). The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms.. Clinical laboratory , vol.65, no.4.
Baykan, O Et Al. "The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms.," Clinical laboratory , vol.65, no.4, 2019
Baykan, O Et Al. "The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms.." Clinical laboratory , vol.65, no.4, 2019
Baykan, O. Et Al. (2019) . "The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms.." Clinical laboratory , vol.65, no.4.
@article{article, author={O Baykan Et Al. }, title={The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms.}, journal={Clinical laboratory}, year=2019}